GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results

NEXT STORY
The PM360 Magazine Trailblazer Awards 2021 Winners
PREV STORY
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones

NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage ...

author_avatar
NASDAQ Market News

West Yavapai Guidance Clinic Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

author_avatar
NASDAQ Market News

North Americaportable oxygen concentratorsmarket is expected to reach US$ 1,315.42 million by 2027 from US$ 682.73 million in 2019

author_avatar
NASDAQ Market News